Specialist CNS research,
in vivo to ex vivo
Expert neurochemistry and neurobehaviour capabilities to generate PK, PD, target engagement, and efficacy data for novel CNS therapeutics, spanning neurodegenerative and psychiatric disorders including Alzheimer's, Parkinson's, schizophrenia, and depression.
Oncology
Bespoke models, data evaluation and data interpretation for novel therapeutic agents to help build confidence in target biology. We provide evidence of efficacy, supporting the progression of drug candidates towards clinical evaluation.
Stroke
Stroke is the fourth leading cause of death and leading cause of adult disability.
Pharmidex now offers life work for strokes, with our goal being to test and identify ideal candidates that can be advanced to clinical trials.
Respiratory
Pharmidex offers extensive preclinical expertise across key respiratory disease areas, including asthma, COPD, chronic cough and pulmonary infection. We provide PK, PD, target engagement and efficacy data to support progression of candidate therapeutics to clinical development.
Metabolic Disorders
Pharmidex can provide in vitro assays and in vivo animal models to investigate the efficacy of the compounds in metabolic disorders (obesity, diabetes, NASH) and kidney diseases including AKPKD (autosomal dominant polycystic kidney disease).
Autoimmune Disease
Pharmidex provides in vitro and preclinical solutions across a range of autoimmune diseases, including multiple sclerosis, psoriasis, atopic dermatitis, alopecia and vitiligo, combining proof-of-concept studies with PK, PD, toxicological and bioanalytical endpoints to accelerate your research programmes.
Contact Us
Address
167-169 Great Portland Street, Fifth Floor, London, W1W 5PF
Contacts
Email: bd@pharmidex.com
